Estimating carcinogenic potency from a rodent tumorigenicity experiment

Wiley for the Royal Statistical Society
Publication Type:
Journal Article
Journal of the Royal Statistical Society Series C: Applied Statistics, 1987, 36 (2), pp. 121 - 133
Issue Date:
Full metadata record
Files in This Item:
Filename Description Size
Thumbnail2011008619OK.pdf1.31 MB
Adobe PDF
Rodent tumorigenicity experiments are conducted to determine whether a particular substance accelerates tumour development. The association between exposure to this substance and the risk of tumour development can be characterized by a measure of carcinogenic potency. The most commonly used potency measure, the dose effect on the lifetime risk of tumour, may be seriously biased, especially when control and exposed groups differ with respect to longevity. However, more appropriate measures, which account for age at death, are largely unavailable except in the special cases of instantly lethal or nonlethal tumours or tumours with observable onset. In this paper, we propose an estimate of carcinogenic potency based on a proportonal prevalence odds model which applies regardless of tumour lethality and can be calculated using standard statistical methodologies. Furthermore, we show how our estimator can be used to generalize available potency estimators to tumours of any lethalit
Please use this identifier to cite or link to this item: